Hologic today announced that company management will participate in the J.P. Morgan SMid Conference, Lazard Capital Markets Medical Technology Corporate Access Day, and Nasdaq OMX 25th Investor Program.

Hologic today announced the Company will host a presentation for members of the investment community at the 2010 RSNA (Radiological Society of North America) trade show in Chicago, IL. RSNA is the world’s largest medical meeting.

Hologic today announced the signing of an exclusive partnership agreement with SuperSonic Imagine, S.A., an innovative producer of diagnostic ultrasound technology.

Hologic announced today that Hologic has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system.

Hologic announced today that the Company has entered into separate, privately-negotiated exchange agreements under which it will retire $450 million in aggregate principal of the Company’s outstanding 2.00% Convertible Senior Notes due 2037 (“Existing Notes”) in exchange for its issuance of $450 million in aggregate principal of new 2.00% Convertible Exchange Senior Notes due 2037 (“New Notes”).

Hologic will focus on products that are the future of women’s imaging at the Radiological Society of North America (RSNA) meeting at McCormick Place in Chicago, November 28 through December 2, 2010.

November 9, 2010 (Booth #410) – Hologic a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will showcase its Total Office Solution™ at the American Association of Gynecologic Laparoscopists (AAGL) 39th Annual Global Congress of Minimally Invasive Gynecology, November 8-12, 2010, at Caesars Palace in Las Vegas. The Total Office Solution is a comprehensive suite of technologies including the Adiana® permanent contraception system; the NovaSure® endometrial ablation procedure for heavy menstrual bleeding; and the THS® tower-free hysteroscopy system, which enables OB/GYNs to perform non-invasive hysteroscopic procedures in the comfort of their offices.

Hologic today announced the long-term, five-year results from the American Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy Registry Trial (ASBS Registry) while showcasing the MammoSite ML (multi-lumen) system at the 52nd ASTRO (American Society for Radiation Oncology) Annual Meeting in San Diego October 31 through November 4, 2010.

Hologic today announced a new survey indicates that for millions of women, the ultimate nine-month adventure may be getting underway this fall. In the survey, nearly 60 percent of moms said fall and winter are the best time to conceive a baby.

Hologic today announced plans to release its fourth quarter fiscal 2010 operating results on Monday, November 8, 2010 after market close. In conjunction with the release, management will host a conference call on Monday, November 8, 2010, at 5:00 p.m. (eastern).

Hologic today announced that Rob Cascella, Hologic’s President and Chief Executive Officer, will preside over the NASDAQ Stock Exchange Opening Bell Ceremony marking the start of Breast Cancer Awareness Month. The event is scheduled to begin at 9:15 a.m. (ET) on October 1, 2010.

Hologic announced that the Radiological Devices Panel (Panel) of the U.S. Food and Drug Administration (FDA) today unanimously voted that Hologic’s Pre‐Market Approval (PMA) demonstrated both the effectiveness and safety of the Company’s Selenia Dimensions three‐dimensional (3‐D) digital mammography tomosynthesis system, “Selenia Dimensions 3‐D.”

Hologic today announced that Rob Cascella, President and Chief Executive Officer, will present at the 2010 Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:45 p.m. (Eastern).

Hologic announced that Glenn Muir, Chief Financial Officer, will present at the Canaccord Genuity 30th Annual Growth Conference 2010 on Wednesday, August 11, 2010 at 1:00 p.m. (Eastern).

Hologic announced today the completion of its acquisition of Sentinelle Medical Inc. (Sentinelle Medical), a leading provider of Magnetic Resonance Imaging (MRI) breast coils, tables and visualization software.

Hologic today announced that on July 1, 2010, the Norwegian cervical screening program began reimbursing for liquid-based cytology (LBC).

Hologic announced that the Company’s Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system has been scheduled to be reviewed by the Radiological Devices Panel (Panel) of the U.S. Food and Drug Administration (FDA) on September 24, 2010 as part of the Company’s pre-market approval (“PMA”) application.

Hologic announced plans to release its third quarter fiscal 2010 operating results on Monday, August 2, 2010 after market close.

Hologic announced that final data analysis from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented in Montreal Canada at the 26th International Papillomavirus Conference.

Hologic announced today that it has entered into a definitive agreement to acquire Sentinelle Medical Inc. (Sentinelle Medical), a leading provider of Magnetic Resonance Imaging (MRI) breast coils, tables and visualization software.

Hologic To Present At The 2010 Wells Fargo Securities Healthcare Conference in Boston on June 23rd, 2010 at 11:15 a.m.

Hologic announced today that the Hologic Selenia® digital mammography system with a tungsten tube has received “Mammographic Type Test” certification by the European Reference Organization (EUREF) Council for Quality Assured Breast Screening and Diagnostic Services.

Hologic To Present At The 9th Annual Needham Healthcare Conference in New York City on June 9th, 2010 at 9:20 a.m.

Hologic To Present At Jefferies 2010 Global Life Sciences Conference in New York City on June 8th, 2010 at 8:00 a.m. Interested parties are invited to listen to the live audio webcasts of Hologic's investor presentations on the investor section of the company's website at www.hologic.com/investor. An archive of the presentations will be available for replay following each conference.

Hologic celebrates a new era of birth control options for women today with the availability of its Adiana® permanent contraception system.

Hologic today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

Hologic today announced it has entered into a settlement agreement with Ethicon Endo-Surgery, Inc. (EES), a Johnson & Johnson company.

Hologic today announced the expansion of its Promise to Me global women’s health initiative to raise awareness and provide donations for women who lack access to cervical cancer screening.